Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Nivagen Pharmaceuticals

Request full access

Company engaged in the development, acquisition, and sales of generic prescription drugs and over-the-counter products for the north american market

Rancho Cordova, United StatesFounded 2009Biotech & Life Sciences

About Nivagen Pharmaceuticals

Nivagen Pharmaceuticals is engaged in the development, acquisition, and sales of generic prescription drugs and over-the-counter (OTC) products for the North American market. The company focuses on leveraging global partnerships with FDA-approved manufacturing facilities to deliver high-quality products at affordable prices. Nivagen's business model includes identifying and utilizing the world's best and most economical Contract Research Organizations (CROs) and Contract Research and Manufacturing Services (CRAMs) to develop and manufacture niche products. The company serves a diverse range of clients, including small FDA-qualified manufacturers looking to launch their products in the U.S. market. Nivagen's core strengths lie in its ability to launch new generic products and its highly skilled sales and marketing team. The company operates in a market where approximately $60 billion is spent on generic prescriptions annually, with over $120 billion worth of products expected to come off patent protection in the next decade. Nivagen generates revenue through product development, co-development, acquisition, in-licensing, and providing sales and marketing services. The company is actively seeking partnerships with CROs and CRAMs for co-development and is also acquiring existing products to expand its portfolio.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
152
Open positions
16
Dealroom signal
58.4/100
Industry
Health, Marketing
Sub-industry
Pharmaceutical
Sector
Supply Chain Management, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Jan 2026 $0 — PAI Pharma ↗
GROWTH EQUITY VC✓Equity / VC May 2020 $16M — Telegraph Hill Partners ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Nivagen Pharmaceuticals website traffic

Latest recorded traffic for Nivagen Pharmaceuticals is 6.4K monthly website visits, up 10.3% over the last three months. Nivagen Pharmaceuticals's team grew 40.7% over the past year.

Latest monthly visits6.4K 3-month web change+10.3% 1-year team growth+40.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Nivagen Pharmaceuticals in the Rancho Cordova ecosystem

Live from Dealroom

The Nivagen Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • Telegraph Hill Partners

Other known investors2 additional known investors

  • PAI Pharma
  • Corbel Capital Partners
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States78.7%
🇮🇳 India21.4%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Nivagen Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Nivagen Pharmaceuticals’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.